Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26
Rhea-AI Summary
Chemed (NYSE: CHE) will release fourth-quarter 2025 financial results for the period ended December 31, 2025 on Wednesday, February 25, 2026 after market close. The company will host a conference call and webcast at 10:00 a.m. ET on Thursday, February 26, 2026 to discuss results and provide a business update.
Investors may access a live webcast via Chemed's Investor Relations website or the provided media-server link. Registration for teleconference dial-in is required and will provide a personalized conference code; callers are asked to dial in 15 minutes early. A taped replay will be available roughly two hours after the call via the investor relations webcast. Chemed operates two subsidiaries: VITAS Healthcare and Roto-Rooter.
Positive
- None.
Negative
- None.
Market Reality Check
Peers on Argus
CHE was down 0.69% while key peers OPCH (-0.9%), DVA (-0.18%), ENSG (-1.43%), AMED (-0.03%), and SGRY (-1.02%) also showed modest declines, but no momentum scanner signals or shared headlines indicated a coordinated sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 04 | Conference presentation | Neutral | -1.5% | Announcement of BofA virtual home care conference presentation and webcast access. |
| Nov 25 | Brand awareness news | Neutral | +1.0% | VITAS hospice-care video release highlighting home hospice caregiver experience. |
| Nov 07 | Dividend declaration | Positive | +0.9% | Declaration of <b>$0.60</b> quarterly dividend, continuing a 218-quarter streak. |
| Nov 04 | Conference presentation | Neutral | -0.4% | UBS Global Healthcare Conference appearance with live webcast and posted materials. |
| Oct 28 | Earnings report | Neutral | +0.5% | Q3 2025 results with revenue growth but lower GAAP and adjusted EPS year over year. |
Recent news flow has been mainly routine (conferences, dividend, quarterly results), with modest single-day price reactions that generally align with the neutral-to-slightly-positive nature of announcements.
Over the past few months, Chemed has reported Q3 2025 results, maintained a quarterly dividend of $0.60 per share, and participated in multiple healthcare conferences. Q3 2025 revenue was $624.9M with adjusted diluted EPS of $5.27. Price reactions to these items were modest (within about 1–2%), suggesting investors have treated recent announcements as incremental rather than thesis-changing. Today’s scheduling of the Q4 2025 earnings release fits this pattern of routine investor communications.
Market Pulse Summary
This announcement sets the timeline for Chemed’s Q4 2025 earnings release on February 25, 2026 and its conference call on February 26, 2026. Investors may contextualize these events against Q3 2025 results, which included revenue of $624.9M and adjusted diluted EPS of $5.27. Key considerations include trends at VITAS and Roto-Rooter, capital allocation updates, and any revisions to guidance once Q4 numbers are reported.
Key Terms
webcast technical
forward-looking statements regulatory
hospice care medical
AI-generated analysis. Not financial advice.
CINCINNATI, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2025, on Wednesday, February 25, 2026, following the close of trading on the New York Stock Exchange.
Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, February 26, 2026, to discuss the company's quarterly results and to provide an update on its business.
Participants may access a live webcast of the conference call through the investor relations section of Chemed’s website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/srzsz65g.
Participants may also register via teleconference at https://register-conf.media-server.com/register/BIe4160b0d86fb4a3cb11588d64e00d9e7.
Once registration is completed, participants will be provided with a dial-in number containing a personalized conference code to access the call. All participants are instructed to dial-in 15 minutes prior to the start time.
A taped replay of the conference call will be available beginning approximately two hours after the call's conclusion. You may access the replay via webcast through the investor relations section of Chemed’s website.
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.
Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.
CONTACT:
Michael D. Witzeman
(513) 762-6714
FAQ
When will Chemed (CHE) report fourth-quarter 2025 earnings?
What time is the Chemed (CHE) earnings conference call for Q4 2025?
How can investors access the Chemed (CHE) Q4 2025 webcast and replay?
Do I need to register to join Chemed (CHE) Q4 2025 teleconference?
When will the taped replay of Chemed's (CHE) Q4 2025 call be available?
Who should I contact for more information about Chemed (CHE) investor access?
